- Select a blog category
April 30th is National Take Back Day in the US. Take back events encourage consumers/patients to return unused medicines that are lying around their homes to pharmacies, so that they can be disposed of properly. This reminded me of a recent experience that troubled me enormously.
We’ve often written blogs about the adoption of innovation and how innovation and technology is helping to support healthcare providers to work differently but it can often feel a little remote to our everyday experiences. This week I’m delighted to share with you a blog written by one of our Monitor Deloitte colleagues who took a sabbatical in late 2015 from her role as a Strategy Consultant in order to support the development of micro-enterprises in rural Nicaragua.
Earlier this week I was discussing our up and coming Healthcare and Life Sciences Essentials course with a new joiner Pavithra Rallapalli, known as Pavi, who recently completed her Post doctoral fellowship at University College London. Her experience was facinating and, not one to miss a chance, I asked Pavi whether she might be interested in writing a Centre blog, and if so what would she want to write about.
This week we’re delighted to feature a ‘my take’ written by our US colleague Harry Greenspun – MD, Director, Center for Health Solutions. We thought it would strike a cord with those fair weather cyclists who are starting to emerge from winter hibernation, but also to those of us interested in learning how the US Med-Tech industry is adapting to new value based payment models.
Some of you reading this blog may already be hooked on the new BBC One drama, The A Word, which shows the reverberation felt across one seemingly perfect family when its youngest member, Joe, is diagnosed with autismi. Others may have seen it advertised and thought the subject matter didn’t resonate or would be too uncomfortable to watch. Certainly that was my husband’s initial reaction but watch it he did and we both found portrayal of this much misunderstood condition very enlightening. Not only does it provide some idea of how wide and varied the condition is, it also highlights that being given a diagnosis is not only life changing for the child, but also for the whole family. As it happens, next week, Saturday 2 April to Friday 8 April, is World Autism Awareness Weekii so I thought I’d use this week’s blog to provide some facts, figure and insights on autism and contribute in a small way to raising awareness about the condition.
The UK, like most other European governments, are facing increasing pressure on their health budgets. One of the reasons for this is the acceleration of medical innovations which are increasing the demand for state-of-the-art treatment. As a result, governments need to get more value for their spending and are considering how best to incentivise “value-based healthcare” (outcomes of health treatment relative to cost).
The Centre for Health Solutions report Better Care for Frail Older People highlighted the challenge of caring for an increasingly frail and ageing population, including the need to improve access to care in all places of care. This week’s blog is a personal take from one of our senior consultants who spent seven years of his career working for a major aged care provider in the UK, where he saw first-hand the pressures that the sector is facing in dealing with an ever-ageing population and increasing numbers of people suffering from dementia. An experience that led him to question whether there will still be a care home sector in 2030?
In December 2015 we launched our sixth annual report on ‘Measuring the return from pharmaceutical innovation’. Our research highlights the difficulties that the largest pharmaceutical companies face in delivering sustainable returns on their late stage R&D pipelines. Indeed, while the cost to develop an asset has increased by a third since we started our analysis six years ago, forecast average peak sales has declined by half. Additionally, our measure of forecast R&D return on investment (RoI) has also shown a significant downward trend, with the average across the 12 companies declining from over ten per cent in 2010 to just over four per cent in 2015.
This week we’re delighted to share an article written by Harry Greenspun: MD, Director – Deloitte (US) Center for Health Solutions. In his ‘My Take’, Harry explores the potential for consumers to adopt new technologies which bring healthcare closer to home:
I embrace technology to the point that my home mirrors the International Space Station. I can remotely adjust its systems, assess its inhabitants (both two- and four-legged), and order supplies that are unlikely to be obtained if not delivered right to my house.
Since the start of 2016, bad news stories about the state of the NHS have proliferated, from a larger than expected deterioration in the state of NHS finances, to the junior doctors strike; alongside evidence of increases in waiting times, cancelled operations and bed occupancy figures. All pointing to an NHS under siege with concerns over quality of care increasing. The publication this week, of the King’s Fund report on Improving Quality in the English NHS: A strategy for actioni, provides a timely reminder of the importance of building capability for quality improvement in each and every NHS organisation. This week’s blog provides my take on the report and the discussion that accompanied its launch.
On 7th February the Health Secretary, Jeremy Hunt’s announced that the NHS would receive a £4.2 billion package of investment in health technology over the next five years, to move it towards a digital, ‘paper-free’ future.i This announcement not only throws up a number of challenges for the NHS it has also rekindled memories of past attempts at modernising the NHS IT infrastructure. In this week’s blog, Rebecca George, Head of our Public Sector Health team, shares her reaction to this strategically important announcement.